learndrugs
Mental & Behavioral Health

Attention-Deficit/Hyperactivity Disorder (Adult)

ADHD Verified · Sep 2026

NIMH: "Attention-deficit/hyperactivity disorder (ADHD) is marked by a persistent pattern of inattention and/or hyperactivity and impulsivity that makes it hard to function in at least two areas of life, such as at home, school, or work." "ADHD is considered a developmental disorder because symptoms must begin in childhood—but many adults also have ADHD."

For the nurse, adult ADHD is mostly a medication-safety topic: screen for heart disease and substance-use risk before stimulants, check blood pressure and heart rate, teach morning dosing, locked storage and never sharing pills, and know the few red flags — chest pain or fainting, new psychosis or mania, priapism, and signs of overdose.

What’s going wrong in the body

The normal physiology, where it fails, and why the body’s compensation backfires.

01 An executive-function disorder of frontal circuits

StatPearls: "It is considered a dysfunction of executive functioning, predominantly a frontal lobe activity. Therefore, patients with ADHD show disability not only in attention and focus but also in decision making and emotional regulation."

Smaller, quieter circuits. "The anterior cingulate gyrus and dorsolateral prefrontal cortex (DLFPC) are found to be small in individuals who are suffering from ADHD. It is thought that these changes account for the deficits in goal-directed behavior. Moreover, activity in the frontostriatal region is also reduced in these individuals as measured by fMRI" (StatPearls).

Dopamine and norepinephrine. "research has shown that the receptors are decreased in the frontal lobes in individuals with ADHD." "There is also evidence for the role of noradrenergic receptor involvement in ADHD" (StatPearls). This is why drugs that raise dopamine and norepinephrine help.

No lab or scan makes the diagnosis. "It is important to remember that ADHD is a clinical diagnosis. There are no standard laboratory or imaging results among patients with ADHD" (StatPearls).

Heritable differences in frontal circuits and catecholamine signaling produce executive dysfunction, seen as inattention, hyperactivity-impulsivity and poor emotional regulation (StatPearls).

02 Childhood onset, adult persistence

Three presentations. "Based on their symptoms, a person can be diagnosed with one of three types of ADHD: inattentive, hyperactive-impulsive, or combined" (NIMH). Open RN: "A person’s symptoms of ADHD can change over time, and their predominant presentation may change."

What changes with age. "Symptoms continue into adulthood for many people with ADHD, but they may change with age. For instance, inattentive symptoms often persist as people get older, whereas hyperactivity and impulsivity are more likely to decline" (NIMH). StatPearls: "In adults, however, these core symptoms may be missing, and they may manifest as other problems, such as procrastination, mood instability, and low self-esteem."

Missed until adulthood. "ADHD symptoms among girls and women are especially likely to have been missed in childhood. Sex differences in diagnosis rates begin to even out in adulthood" (NIMH). Some people have "a milder form of ADHD that could be managed well until faced with the stresses and demands of adulthood, especially at work."

How common. StatPearls: "It is prevalent in around 3%-6% of the adult population." Open RN: "ADHD lasts into adulthood for at least one third of children with ADHD."

Symptoms start in childhood; in adults inattention tends to persist while hyperactivity fades, and many cases are first recognized in adulthood (NIMH).

03 How stimulants work — and why they are controlled

Open RN: "Stimulants block the reuptake of norepinephrine and dopamine in the synapse and increase the overall level of these substances in the brain, but they have a paradoxical calming effect and improve the ability to focus and concentrate for individuals diagnosed with ADHD."

Two families. "Stimulants are further broken into amphetamines and methylphenidates" (StatPearls). "Methylphenidate blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increases the release of these monoamines into the extraneuronal space" (CONCERTA label). "Lisdexamfetamine is a prodrug of dextroamphetamine" (VYVANSE label).

Same effect, two sides. The same catecholamine rise that improves focus also raises blood pressure and heart rate, suppresses appetite, disturbs sleep and carries reward-driven misuse potential: "they are a Schedule II controlled substance because they have a high potential for misuse and dependence" (Open RN).

Treated ADHD lowers substance risk. "there is an increased risk of substance use in patients with ADHD, and studies show treating with a stimulant decreases their overall lifetime risk of substance abuse" (StatPearls). NIMH: misuse or dependence is "unlikely when the medications are used as prescribed."

Raising dopamine and norepinephrine improves focus but also drives the expected cardiovascular, appetite and sleep effects and the misuse risk behind the boxed warning (Open RN; CONCERTA and VYVANSE labels).

Causes & risk factors

Modifiable factors are teaching targets — the patient can act on them.

Genetics — "It is one of the most heritable conditions in terms of psychiatric disorders"; "Siblings have twice the risk of having ADHD than the general population" (StatPearls) Prenatal and early exposures — "Alcohol and tobacco use during pregnancy," "Premature delivery," "Low birth weight," "Brain injury," and environmental risks such as lead (Open RN) Not caused by sugar, TV or parenting — "Research does not support popularly held views that ADHD is caused by eating too much sugar, watching too much television, or ineffective parenting" (Open RN) Sex — StatPearls reports a 2:1 male-to-female ratio, with the inattentive subtype "more common among the female population"; girls and women are more often missed in childhood (NIMH)

Signs & symptoms

Each finding tied to the mechanism that produces it — and the triage it calls for.

Inattention and disorganization early Expected
Why: NIMH: "Difficulty paying attention, staying on task, or being organized"; "Disorganization and procrastination"; "Poor time management, planning, or organization"; "Frequently losing things or being forgetful in activities."
Restlessness and impulsivity Expected
Why: NIMH: "Feelings of restlessness and a need for constant activity or stimulation," "Frequently interrupting others or being very talkative," and "Choosing immediate rewards over future rewards or consequences."
Work, money and relationship problems Expected
Why: NIMH: "Adults with ADHD often have a history of poor academic performance, work problems, or strained relationships"; "Teens and adults with ADHD are more likely to engage in risky behaviors, such as substance use and unsafe sexual activity, and are at increased risk for poor job performance and financial problems."
Sleep problems Expected
Why: NIMH: "Sleep problems are especially prevalent, affecting up to 70% of adults with ADHD." Stimulants can add insomnia.
On a stimulant: poor appetite, weight loss, insomnia, headache, dry mouth; small rise in BP and HR Expected
Why: CONCERTA adults: "decreased appetite, headache, dry mouth, nausea, insomnia, anxiety, dizziness, weight decreased, irritability, tachycardia, and hyperhidrosis." Mean increases of "approximately 2 to 4 mm Hg" and "approximately 3 to 6 beats per minute" (label).
Blood pressure or heart rate climbing beyond baseline on treatment Hold & notify
Why: "Some patients may have larger increases. Monitor all CONCERTA-treated patients for hypertension and tachycardia" (label).
New hallucinations, delusions or manic symptoms on a stimulant Hold & notify
Why: The label warns stimulants "may cause psychotic or manic symptoms (e.g., hallucinations, delusional thinking, or mania) in patients without a prior history of psychotic illness or mania"; "If new psychotic or manic symptoms occur, consider discontinuing CONCERTA."
Signs of misuse or diversion Hold & notify
Why: "Misuse and abuse of CONCERTA may cause increased heart rate, respiratory rate, or blood pressure; sweating; dilated pupils; hyperactivity; restlessness; insomnia; decreased appetite" (label). Open RN: "Up to 29 percent of school- and college-aged students with stimulant prescriptions have been asked to give, sell, or trade their medication."
Unexplained wounds on fingers or toes; color change or numbness Hold & notify
Why: Peripheral vasculopathy, including Raynaud’s: "Call your healthcare provider right away if you or your child have any signs of unexplained wounds appearing on fingers or toes during treatment with CONCERTA" (label).
Chest pain, shortness of breath or fainting on a stimulant Report immediately
Why: Label Medication Guide: "Call your healthcare provider or go to the nearest hospital emergency room right away if you or your child have any signs of heart problems, such as chest pain, shortness of breath, or fainting during treatment with CONCERTA."
Painful or prolonged erection (priapism) Report immediately
Why: "CONCERTA-treated patients who develop abnormally sustained or frequent and painful erections should seek immediate medical attention" (label).
Thoughts of suicide or a life-threatening situation Report immediately
Why: NIMH: "If you or someone you know is struggling or having thoughts of suicide, call or text the 988 Suicide & Crisis Lifeline"; "In life-threatening situations, call 911."

Diagnostics

Test In this disorder Normal
Clinical interview and rating scales NIMH: "adults must have shown symptoms much earlier, starting before age 12." "Adults or adolescents over 16 years must show five (instead of six) symptoms of inattention or hyperactivity and impulsivity," lasting "at least 6 months." "Complete clinical interviews, behavior rating scales, or symptom checklists to determine whether you meet the criteria for a diagnosis of ADHD." StatPearls names the Brown Attention Deficit Disorder Scale for adults. Persistent, impairing symptoms across settings; symptoms began before age 12 NIMH, StatPearls —
Collateral history "Diagnosing ADHD in adulthood is complicated by the need to show symptoms before age 12. For this reason, a diagnosis relies heavily on past reports of behavior." Clinicians "may ask to talk to people who know you well, such as a partner, family members, and friends" (NIMH). Reports from partner, family, school records NIMH —
Rule out mimics and co-occurring conditions "It should not be diagnosed in the context of symptoms from another disorder, for example, a psychotic episode or manic episode." "Substance abuse disorders should also be carefully examined." A physical exam "can still be used to exclude medical causes such as thyroid problems" (StatPearls). Mood, anxiety, sleep, substance use and thyroid problems considered StatPearls —
Pre-stimulant screening CONCERTA label: "Prior to treating patients with CONCERTA, assess: For the presence of cardiac disease"; "Before prescribing CONCERTA, assess each patient's risk for abuse, misuse, and addiction"; "screen patients for risk factors for developing a manic episode (e.g., history of depressive symptoms or a family history of suicide, bipolar disorder, or depression)." Cardiac history, BP, HR; abuse/misuse risk; mania risk FDA label —

Complications

Black-box warning — most severe: ■ Stimulants — abuse, misuse and addiction Hold & notify
"CONCERTA has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction." The same boxed text appears on the VYVANSE label. "CONCERTA contains methylphenidate, a Schedule II controlled substance."
"Misuse and abuse of CNS stimulants, including CONCERTA, can result in overdose and death" and "this risk is increased with higher dosage or unapproved methods of administration, such as snorting or injection." "Educate patients and their families about these risks, proper storage of CONCERTA, and proper disposal of any unused drug" (label).
Warning: Stimulants — sudden death, stroke, MI with heart disease Report immediately
"Sudden death has been reported in patients with structural cardiac abnormalities or other serious cardiac disease who were treated with CNS stimulants at the recommended ADHD dosage" (label). Open RN: "Sudden death, stroke, and myocardial infarction have been reported in adults with CNS-stimulant treatment at recommended doses."
"Avoid CONCERTA use in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease." Chest pain, shortness of breath or fainting → emergency room right away (label).
Warning: Stimulant overdose Report immediately
"Overdose of CNS stimulants is characterized by the following sympathomimetic effects: Cardiovascular effects including tachyarrhythmias, and hypertension or hypotension." "Life-threatening hyperthermia (temperatures greater than 104°F) and rhabdomyolysis may develop" (label).
"If you or your child take too much CONCERTA, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away" (label).
Warning: Serotonin syndrome (lisdexamfetamine + serotonergic drugs) Report immediately
"Discontinue treatment with VYVANSE and any concomitant serotonergic agents immediately if symptoms of serotonin syndrome occur, and initiate supportive symptomatic treatment" (label).
"Advise patients to contact their healthcare provider or report to the emergency room if they experience signs or symptoms of serotonin syndrome" (VYVANSE label). Stimulants are also contraindicated with MAO inhibitors or within 14 days of stopping one, "because of the risk of a hypertensive crisis" (CONCERTA label); atomoxetine is likewise contraindicated when "Taking, or within 14 days of stopping, a monoamine oxidase inhibitor (MAOI)" (STRATTERA label).
Warning: Atomoxetine — severe liver injury Hold & notify
"STRATTERA should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury." "Rare cases of liver failure have been reported during postmarketing use, including a case that resulted in a liver transplant" (label).
"Patients should be instructed to contact their healthcare provider immediately should they develop pruritus, dark urine, jaundice, right upper quadrant tenderness, or unexplained" flu-like symptoms (label).
Caution: Atomoxetine — mood and behavior changes Hold & notify
The boxed suicidality warning applies to pediatric patients: "A similar analysis in adult patients treated with STRATTERA for ADHD did not reveal an increased risk of suicidal ideation or behavior" (label).
All ages, per the Medication Guide: "Pay close attention to, and tell your healthcare provider right away about, any changes, especially sudden changes, in mood, behavior, actions, thoughts, or feelings, or suicidal thoughts or actions." Thoughts of suicide at any age are also the NIMH emergency cue above (988; 911 if life-threatening).
Caution: Untreated ADHD
"However, untreated ADHD can cause persisting dysfunction, and devastating consequences include but are not limited to long-term inability to work, increased car accidents, and increased substance use" (StatPearls).
"Noncompliance with medications is common, and follow-up is difficult as many patients seek alternative treatments" (StatPearls).

Medications for this condition

Why each class is prescribed here — every card links to its full pharmacology page.

CNS Stimulants (ADHD) First-line
Nervous · methylphenidate

First-line. "Stimulants are the mainstay of treatment for ADHD. They are effective in about 70% of patients" (StatPearls). NIMH lists "Medication, usually stimulant medications" among the most common adult treatments, and "stimulant medications can be helpful for adults, as well as for children and adolescents, with ADHD." Methylphenidates and amphetamines (including lisdexamfetamine) come in immediate- and extended-release forms. Take in the morning: "avoid afternoon doses because of the potential for insomnia" (VYVANSE label). Extended-release tablets: "swallow CONCERTA whole with liquids, and not to split, crush, or chew" (label). Stimulant use for ADHD "is safe in epilepsy" (StatPearls).
Atypical Antidepressants
Nervous · bupropion

Bupropion — an option, not first-line. StatPearls: "Other antidepressants include bupropion, which targets dopamine and norepinephrine, and TCAs, which are the last-choice options." Open RN notes bupropion "does decrease seizure threshold."

Beyond medications

  • Atomoxetine (non-stimulant). "STRATTERA is indicated for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients 6 years of age and older." "STRATTERA contains atomoxetine which is not a controlled substance" (label). StatPearls: "It is known to be effective in many trials as a treatment option for ADHD, though not nearly as effective as stimulants." Monitor: "Heart rate and blood pressure should be measured at baseline, following STRATTERA dosage increase, and periodically while on therapy"; "Urinary retention or hesitancy may occur." Contraindicated "With narrow angle glaucoma" and "With pheochromocytoma or a history of pheochromocytoma." Warning: "Hypersensitivity reactions included anaphylaxis, angioneurotic edema, urticaria, and rash"; "Tell your healthcare provider right away if trouble breathing, hives, rash, or swelling of the face, eyes, lips, or throat develop during treatment" (label).
  • Alpha agonists. "Lastly, alpha agonists such as clonidine and guanfacine can be used as an effective treatment for ADHD." "They are found to be more effective in younger children than adults" (StatPearls).
  • Psychotherapy. NIMH: "Psychotherapy, like behavioral and cognitive behavioral therapy." StatPearls: cognitive-behavioral training programs "prove to be very effective when used along with pharmacotherapy." "Effective treatment often involves a combination of elements" (NIMH).
  • Coaching, exercise and work supports. "Some adults may find it helpful to get support from a life coach or ADHD coach who can teach them executive function skills to improve daily functioning. Others try lifestyle changes, like adding more physical exercise to their daily schedule." "People whose ADHD symptoms cause impairment at work may qualify for reasonable accommodations under the Americans with Disabilities Act" (NIMH).
  • Alcohol. Open RN: "Alcohol should be avoided."
  • Never too late. "It is never too late to seek a diagnosis and treatment for ADHD and any other mental health condition that may occur with it" (NIMH).

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Before and during stimulant therapy
Screen cardiac history, baseline BP and HR, and substance-use and mania risk before the first dose.
Why: The label requires assessment "For the presence of cardiac disease," of "each patient's risk for abuse, misuse, and addiction," and of risk factors for a manic episode.
Recheck BP and HR at follow-up visits and report sustained rises.
Why: "Monitor all CONCERTA-treated patients for hypertension and tachycardia" (label).
Track appetite, weight and sleep.
Why: Decreased appetite, weight loss and insomnia are among the most common adult effects (label).
Ask about new psychotic or manic symptoms, and hold/report if they appear.
Why: "If new psychotic or manic symptoms occur, consider discontinuing CONCERTA" (label).
Teaching: safe use of a controlled drug
Teach locked storage, never sharing, and take-back disposal.
Why: "Advise patients to store CONCERTA in a safe place, preferably locked, and instruct patients to not give CONCERTA to anyone else" (label). Open RN: dispose of unused stimulants per state law or "a medicine take-back program."
Take in the morning; swallow extended-release tablets whole.
Why: "avoid afternoon doses because of the potential for insomnia" (VYVANSE label); do "not to split, crush, or chew, the extended-release tablets" (CONCERTA label).
Do not stop abruptly after long use without talking to the prescriber.
Why: Withdrawal after abrupt discontinuation "included dysphoric mood; depression; fatigue; vivid, unpleasant dreams; insomnia or hypersomnia; increased appetite" (label).
Teach red flags: chest pain, shortness of breath or fainting; painful prolonged erection; finger or toe wounds; taking too much.
Why: The label sends heart symptoms and overdose to the nearest hospital emergency room right away, and says patients with a painful, sustained erection "should seek immediate medical attention."
Atomoxetine and whole-person care
On atomoxetine, teach to report jaundice, dark urine, itching or RUQ tenderness immediately, and mood changes right away.
Why: The label: "Patients should be instructed to contact their healthcare provider immediately" for liver symptoms, and the drug "should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury."
Screen for co-occurring depression, anxiety, sleep problems and substance use.
Why: NIMH: ADHD "often co-occurs with other mental disorders and can make them harder to treat." StatPearls: "Treatment of ADHD can improve the symptoms of these other disorders."
Support follow-up and adherence; link to therapy, coaching and workplace accommodations.
Why: "Patients with ADHD must be followed up regularly to check on their symptoms and comorbidities" (StatPearls).

How a real nurse thinks

The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.

  1. 1
    Recognize cues

    BP and HR well above baseline, insomnia with midday dosing, appetite loss, chewing an extended-release tablet, and a diversion request.

  2. 2
    Analyze cues

    Stimulants raise BP and HR and some patients "may have larger increases." Afternoon doses cause insomnia. Chewing defeats the extended-release design. Sharing is the misuse pathway behind the boxed warning.

  3. 3
    Prioritize

    Notify the prescriber about the BP/HR rise (hold-notify), then correct administration and address storage and diversion.

  4. 4
    Generate solutions

    Report vitals; teach morning dosing and swallowing whole; teach locked storage and never sharing; ask about chest pain, palpitations or fainting; review appetite strategies.

  5. 5
    Take action

    Recheck BP after rest, notify the prescriber, ask directly about cardiac symptoms, and provide teaching with teach-back.

  6. 6
    Evaluate

    At the next visit BP and HR are near baseline after the prescriber’s adjustment, the tablet is taken whole each morning, sleep is better, and the medicine is kept locked.

Scenario — you’re the nurse

Work each question before revealing the answer. Rationales explain the wrong options too.

Primary care follow-up · adult ADHD

A 34-year-old accountant started an extended-release methylphenidate tablet 4 weeks ago. Focus at work has improved.

Vitals — BP 142/90 (baseline 124/78), HR 104 (baseline 76)
Sleep/appetite — trouble falling asleep; skipping lunch; 2 kg weight loss
Use — takes the tablet around noon ‘when the day gets busy’; sometimes chews it
Other — mentions a roommate asked to ‘borrow a few’ before exams
Q1 Select all that apply
Which teaching points are correct for an adult starting a stimulant for ADHD? Select all that apply.
  1. A. Store the medicine in a safe, preferably locked, place
  2. B. Take it in the morning to avoid insomnia
  3. C. Split or chew the extended-release tablet if it is hard to swallow
  4. D. Never give the medicine to anyone else
  5. E. Go to the emergency room right away for chest pain, shortness of breath or fainting
Reveal answer & rationale
Answer: A, B, D, E
Labels: "store CONCERTA in a safe place, preferably locked, and instruct patients to not give CONCERTA to anyone else"; "avoid afternoon doses because of the potential for insomnia"; do "not to split, crush, or chew, the extended-release tablets"; heart symptoms → "go to the nearest hospital emergency room right away."
Q2 Multiple choice
Which finding in a client taking a stimulant requires emergency care?
  1. A. Decreased appetite with a 1-kg weight loss
  2. B. Difficulty falling asleep
  3. C. A painful erection lasting several hours
  4. D. Dry mouth and headache
Reveal answer & rationale
Answer: C
The label says patients who develop "abnormally sustained or frequent and painful erections should seek immediate medical attention." Appetite loss, insomnia, dry mouth and headache are expected, common adult adverse effects to teach and monitor.
Q3 Multiple choice
An adult with ADHD and a history of stimulant misuse asks about a non-controlled option. Which medication fits?
  1. A. Lisdexamfetamine
  2. B. Methylphenidate
  3. C. Atomoxetine
  4. D. Dextroamphetamine
Reveal answer & rationale
Answer: C
"STRATTERA contains atomoxetine which is not a controlled substance" and it is indicated for adults. Methylphenidate and amphetamines, including the lisdexamfetamine prodrug, are Schedule II with a boxed warning for abuse, misuse and addiction.
Q4 Multiple choice
A client on atomoxetine reports dark urine and itching. What is the nurse’s best action?
  1. A. Reassure the client that these are expected effects
  2. B. Tell the client to double the fluid intake and recheck in a month
  3. C. Hold the medication and contact the provider immediately
  4. D. Switch the client to an afternoon dose
Reveal answer & rationale
Answer: C
The atomoxetine label says to "contact their healthcare provider immediately" for pruritus, dark urine, jaundice or right upper quadrant tenderness, and the drug "should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury."

Common questions

What causes attention-deficit/hyperactivity disorder (adult)?
Common causes and risk factors include genetics — "it is one of the most heritable conditions in terms of psychiatric disorders"; "siblings have twice the risk of having adhd than the general population" (statpearls), prenatal and early exposures — "alcohol and tobacco use during pregnancy," "premature delivery," "low birth weight," "brain injury," and environmental risks such as lead (open rn), not caused by sugar, tv or parenting — "research does not support popularly held views that adhd is caused by eating too much sugar, watching too much television, or ineffective parenting" (open rn), sex — statpearls reports a 2:1 male-to-female ratio, with the inattentive subtype "more common among the female population"; girls and women are more often missed in childhood (nimh).
What are the early signs of attention-deficit/hyperactivity disorder (adult)?
Early findings include Inattention and disorganization.
Can you be diagnosed with ADHD as an adult?
Yes. "ADHD can be diagnosed in childhood or adulthood. However, adults must have shown symptoms much earlier, starting before age 12" (NIMH).
Do stimulants make addiction more likely?
They carry a boxed warning for abuse, misuse and addiction, so risk is assessed first. But NIMH says misuse or dependence is "unlikely when the medications are used as prescribed," and StatPearls notes treating with a stimulant "decreases their overall lifetime risk of substance abuse."
Can someone with epilepsy take a stimulant?
StatPearls: "recent studies showed that stimulant use for ADHD is safe in epilepsy."
Does atomoxetine have a suicide warning for adults?
The boxed warning is for pediatric patients; "A similar analysis in adult patients treated with STRATTERA for ADHD did not reveal an increased risk of suicidal ideation or behavior." Adults should still report sudden mood or behavior changes right away.

Sources

Reviewed by Hae Suk Lee, RN

Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.

Bookmark LearnDrugs.com?

Your saved pages are kept in this browser. Add LearnDrugs.com to your browser’s bookmarks to get back to them in one click.

Drag this link to your bookmarks bar: LearnDrugs.com

Or press Ctrl + D to bookmark the page you’re on.